Biolife Solutions Stock Today
| BLFS Stock | USD 26.35 1.04 4.11% |
PerformanceWeakest
| Odds Of DistressLow
|
BioLife Solutions is selling for under 26.35 as of the 6th of January 2026; that is 4.11 percent increase since the beginning of the trading day. The stock's lowest day price was 25.31. BioLife Solutions has only a 8 % chance of going through financial distress over the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 7th of December 2025 and ending today, the 6th of January 2026. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 22nd of November 1989 | Category Healthcare | Classification Health Care |
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington. The company has 48.15 M outstanding shares of which 2.78 M shares are currently shorted by private and institutional investors with about 8.01 trading days to cover. More on BioLife Solutions
Moving together with BioLife Stock
Moving against BioLife Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
BioLife Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO and President and Director | Michael Rice | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, SP Small-Cap 600, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsBioLife Solutions can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand BioLife Solutions' financial leverage. It provides some insight into what part of BioLife Solutions' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BioLife Solutions (BLFS) is traded on NASDAQ Exchange in USA and employs 159 people. BioLife Solutions is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.15 B. BioLife Solutions conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 48.15 M outstanding shares of which 2.78 M shares are currently shorted by private and institutional investors with about 8.01 trading days to cover.
BioLife Solutions currently holds about 46.55 M in cash with 8.43 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.09.
Check BioLife Solutions Probability Of Bankruptcy
Ownership AllocationThe majority of BioLife Solutions outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in BioLife Solutions to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in BioLife Solutions. Please pay attention to any change in the institutional holdings of BioLife Solutions as this could imply that something significant has changed or is about to change at the company.
Check BioLife Ownership Details
BioLife Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Geode Capital Management, Llc | 2025-06-30 | 921.1 K | |
| Palisade Capital Management Llc | 2025-06-30 | 919.5 K | |
| Geneva Capital Management | 2025-06-30 | 901.8 K | |
| Royal Bank Of Canada | 2025-06-30 | 791.3 K | |
| Ing Investment Management Llc | 2025-06-30 | 720.1 K | |
| Cramer Rosenthal Mcglynn Llc | 2025-06-30 | 704.2 K | |
| Bank Of America Corp | 2025-06-30 | 671.7 K | |
| Granahan Investment Management Inc.. | 2025-06-30 | 643.2 K | |
| Mutual Of America Capital Management Llc | 2025-06-30 | 638.4 K | |
| Casdin Capital, Llc | 2025-06-30 | 7.7 M | |
| Blackrock Inc | 2025-06-30 | 5.5 M |
BioLife Solutions Historical Income Statement
BioLife Stock Against Markets
BioLife Solutions Corporate Management
| Sarah JD | Chief Officer | Profile | |
| Troy Wichterman | Chief Officer | Profile | |
| Geraint Phillips | Senior Operations | Profile | |
| Troy CPA | Chief Officer | Profile |
Additional Tools for BioLife Stock Analysis
When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.